As a mainstream triazole antifungal active pharmaceutical ingredient, Fluconazole CAS 86386-73-4 fully complies with BP2025 pharmacopoeia standards and is widely used in the production of systemic anti-fungal finished drugs. We are a professional Fluconazole CAS 86386-73-4 API Manufacturer with GMP standardized workshops, supplying high-purity raw materials to global pharmaceutical manufacturers and formulation factories.
Fluconazole CAS 86386-73-4 is a synthetic triazole antifungal API tested strictly in accordance with BP2025 standards. It inhibits fungal cell membrane synthesis and delivers broad-spectrum bacteriostatic effects against Candida, Cryptococcus and dermatophytes, with outstanding blood-brain barrier penetration and high oral bioavailability. We provide Bulk API Order service and maintain Fluconazole CAS 86386-73-4 In Stock year-round, supporting large-scale continuous production of pharmaceutical factories and small trial batches for new formulation development. Our product adopts multi-stage recrystallization purification, with ultra-low single and total impurity levels, fully meeting the raw material quality requirements of generic drug registration in European markets.
Product Parameters (Specification)
Parameter Item
Details
Parameter Item
Details
CAS No.
86386-73-4
Molecular Formula
C₁₃H₁₂F₂N₆O
Appearance
White or almost white crystalline powder
Purity
99.0% ~ 101.0%
Execution Standard
BP/EP/USP
Packaging Specification
25kg/drum
Storage Conditions
Sealed, cool dry place, protected from light
Shelf Life
24 months
Product Features and Applications
Product Features
Broad-spectrum antifungal activity: Effective against superficial and systemic fungal pathogens, covering mucosal, visceral and central nervous system fungal infections;
Excellent pharmacokinetic property: Good oral absorption, stable blood concentration and strong cerebrospinal fluid permeability, suitable for oral and injectable dual formulation development;
Ultra-low impurity index: Key process-related impurities are far below BP2025 limits, reducing safety risks of finished preparations and simplifying registration impurity research;
Strong formulation compatibility: Compatible with most common pharmaceutical excipients, easy to process into tablets, capsules, suspensions and intravenous infusion.
Application Scenarios
Systemic fungal infection preparations: Raw material for drugs treating cryptococcal meningitis, disseminated candidiasis, abdominal and urinary tract fungal infections;
Mucosal antifungal medicines: Used for oral thrush, vaginal candidiasis and chronic atrophic oral candidiasis preparations;
Preventive medication for immunocompromised patients: Raw material for antifungal preventive drugs for chemotherapy, organ transplant and HIV-infected populations;
Dermatological topical preparations: Core raw material for treating tinea corporis, tinea cruris and tinea versicolor.
Procurement and Service Support
As your reliable Fluconazole CAS 86386-73-4 API Manufacturer, we offer full-process professional procurement matching services:
Flexible Bulk API Order tiered pricing: Long-term cooperative pharmaceutical enterprises enjoy exclusive volume discounts and priority production scheduling;
Stable Fluconazole CAS 86386-73-4 In Stock supply: Multiple batches in constant inventory, supporting urgent shipment to avoid production line shutdown caused by raw material shortage;
Complete regulatory supporting documents: Provide BP2025-compliant full COA, batch production records, MSDS and audit documents to meet EU generic drug registration and factory audit requirements;
Customized technical service: Professional R&D team provides formulation compatibility test guidance and impurity control technical support for downstream customers.
Hot Tags: Fluconazole CAS 86386-73-4, China, Manufacturer, Supplier, Factory
If you have any enquiry about quotation or cooperation, please feel free to email or use the following inquiry form. Our sales representative will contact you within 24 hours.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy